Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Amortization of Deferred Charges (2021 - 2025)

Biote has reported Amortization of Deferred Charges over the past 5 years, most recently at $215000.0 for Q4 2025.

  • Quarterly results put Amortization of Deferred Charges at $215000.0 for Q4 2025, changed 0.47% from a year ago — trailing twelve months through Dec 2025 was $826000.0 (up 1.23% YoY), and the annual figure for FY2025 was $833000.0, up 1.71%.
  • Amortization of Deferred Charges for Q4 2025 was $215000.0 at Biote, up from $200000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for BTMD hit a ceiling of $215000.0 in Q4 2025 and a floor of $55000.0 in Q2 2021.
  • Median Amortization of Deferred Charges over the past 5 years was $200000.0 (2022), compared with a mean of $166052.6.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 263.64% in 2022 and later changed 0.0% in 2023.
  • Biote's Amortization of Deferred Charges stood at $56000.0 in 2021, then surged by 251.79% to $197000.0 in 2022, then grew by 3.05% to $203000.0 in 2023, then grew by 5.42% to $214000.0 in 2024, then rose by 0.47% to $215000.0 in 2025.
  • The last three reported values for Amortization of Deferred Charges were $215000.0 (Q4 2025), $200000.0 (Q3 2025), and $200000.0 (Q2 2025) per Business Quant data.